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Mare lactotraasfer~n has been purified and analyzed. Its molecuiar mass is 81 kDa. A 28 amino acid long 
N-terminal sequence was established and a first series of comparisons with other transferrins was performed. 
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1, INTRODUCTION 
Present knowledge concerning Iactotransferrins 
remains limited: indeed, only human lactotransfer- 
rin has been submitted to extensive molecular 
studies devoted to its complete amino acid se- 
quence [1,2] and to the primary structure of the 
glycans linked to the polypeptide chain through 
two N-glycosidic bonds [3] as well as to biological 
studies reviewed in 141: thus molecular and evolu- 
tionary comp~isons with human serum transferrin 
and hen ovotransferrin could be performed [5]. 
Only the purification of bovine [6] and rabbit [7] 
milk lactotransferrins has been further reported. 
Lactotransferrin was claimed to act to deprive the 
gut flora of the free iron required for many com- 
mon gut-associated pathogens [8]. Lysozyme (EC 
3.2.1.17) characterized in human but not in bovine 
milk also represents effective, however non- 
specific, antimicrobial activities: the mechanism of 
its role in the defence of the gut from pathogens, 
yet to be fully explained, is probably intricately in- 
terrelated with other components such as lac- 
totr~sfer~n [g-11]. It was thus tempting to 
develop the study concerning these two com- 
ponents present in various milks. Mare’s milk con- 
tains simultaneously lactotransferrin and 
lysozyme. The latter has already been isolated and 
partially characterized 1121. Here, we deal with the 
purification, analysis and N-terminal sequence 
determination of mare Iactotransferrin. 
2. MATERIALS AND METHODS 
Mare’s milk was obtained from E. Wettstein, 
Fohlenhof, Wermatswil, Switzerland. The milk 
was stored frozen. Hep~in-Seph~ose CL-6B, 
Sephadex G-100 and the Mono SHR 515 column 
(5 x 0.5 cm) were from Pharmacia. All other 
reagents (analytical grade) were purchased from 
Fluka or Merck, except those employed for the Se- 
quencer which were obtained from Pierce or 
S.D.S. (M~seilles). 
2.1. Pre~arar~~~ of whey pmteins 
The milk was thawed at 4”C, centrifuged at 
10000 x g for 30 min and after removal of the 
cream, the skim milk was adjusted to pH 4.7 with 
4 M HCl; the caseins were precipitated by heating 
the milk to 40°C for 30 min. After another cen- 
trifugation at 20000 x g for 30 min, the whey was 
decanted and dialyzed against a 0.005 M 
veronal-HCI, 0.05 M NaCl, pH 7.4 buffer before 
being applied to a column of heparin-Sepharose. 
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Sodium dodecylsulfate-polyacryhunide (10%) 
gel electrophoresis (SDS-PAGE) was performed 
according to [13] at pi-I 8.9 in the presence or 
absence of 1% ~thiothreitol; protein bands were 
stained with Coomassie brilliant blue R-250. 
I 
2.3. Analytical procedures and N-terminal 
sequence determination 
The amino acid composition was determined 
after total hydrolysis (5.6 M HCl, containing 
l/2000 2-mercaptoethanol; 18, 48 h; under 
vacuum) with a Biotro~k LC 6000 Auto~~yzer. 
Cystine was determined as S-carboxymethyl- 
cysteine after reduction and aikylation and trypto- 
phan according to [14]. Automated Edman de- 
gradation was carried out in a Beckman 890 C Se- 
quencer, by the 1 M quadrol method in the 
presence of polybrene 1151. The phenylthiohyd~- 
toin amino acids were identified by thin layer [16] 
and with a Waters Associates ALC/GPC 204 high- 
pressure liquid chromatograph equipped with a 
680 progr~mer, using ap-Bondapak Cl8 column 
(30 x 0.39 cm) [17]. A Radial-Pak p-Bondapak 
Cl8 column (10 x 0.8 cm) was employed to 
separate methionine from valine, arginine from 
glutamic acid and histid~e from leucine using the 
following system: solvent A was 0.02 M sodium 
acetate (pH 6.3)-methanol (9: 1, v/v) and solvent 
B ethanol 95”; a gradient (curve 8) from 5 to 30% 
of solvent B over 16 min was followed by isocratic 
elution with 30% solvent B over 31 min at room 
temperature. The sugars were determined accor- 
ding to [ 181 using a Varian Model 3700 gas 
chromato~aph. 
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F&l. Heparin-Sepharose (25 x 2 cm) chromatography of 250 mi mare whey in 0.005 M veronal-HCl (pH 7.4), 
0.05 M NaCl: only the peaks eked by a linear 0.05-1~0 M NaCf gradient are shown. Flow rate, 10 ml/h. 
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3. RESULTS AND DISCUSSION 
3.1. Purification and molecular mass 
The complete purification of mare lactotransfer- 
rin was achieved by a 2-step procedure. The whey 
proteins were first submitted to a heparin-sepha- 
rose chromatography according to [19] and [20]. 
Lactotransferrin and lysozyme were contained in 
the second peak eluted by the NaCl gradient 
(fig.1). Dialysis prior to Sephadex G-100 filtration 
was done in Spectrapor dialysis tubing with an 
-15000 Da cut-off: a large part of lysozyme was 
thus eliminated. The purity of mare lactotransfer- 
rin obtained after Sephadex G-100 filtration (fig.2) 
was proven: (a) by FPLC-chromatography (Phar- 
macia) (10 mM piperazine-N,N’-bis-2-ethanesul- 
fonic acid (PIPES) buffer, pH 6, with a linear 
O-O.5 M NaCl gradient): a symmetrical peak was 
obtained; (b) by determination of a unique N-ter- 
minal sequence&e below); (c) by SDS-PAGE: a 
unique band was characterized corresponding to a 
OD 
280 “In 
_ ml --t 
Fig.2. Sephadex G-W0 (100 x 1 cm) filtration of the 
second peak eluted by the NaCl gradient of the 
heparin-Sepharose chromatography (fig-l). Eluent: 
0.1 M sodium acetate (pH 6.5). Flow rate, 10 ml/h. 
molecular mass of 81 kDa, in good agreement with 
the molecular masses of human lactotransferrin 
and other transferrins [2,5-71. 
3.2. Amino acid and sugar analyses 
The amino acid composition of mare lac- 
totransferrin, compared to the proteins of human 
and bovine origins, is indicated in table 1. The 
following sugars were characterized (molar ratios 
in parentheses): Gal (4), Man (6), GalNAc (1.5), 
GlcNAc (9.5), NeuAc (1.5). A small quantity of 
GalNAc was also found in bovine lactotransferrin 
[6] whereas the presence of this sugar was not 
reported in the glycans determined in human lac- 
totransferrin [3]. 
3.3. N-terminal sequence determination and 
comparison with other transferrins 
A 28 amino acid long N-terminal sequence of 
mare lactotransferrin was established (table 2). 
When only the first 12 N-terminal amino acids of 
the so far studied transferrins were compared, the 
Table 1 
Amino acid composition (residues per molecule) of mare 
lactotransferrin: average values of 5 analyses after 
different time intervals. Comparison with human 
(according to the complete structure (21) and bovine 1231 
lactotransferrins 
Amino acid 
Asp 
Thr 
Ser 
Glu 
Pro 
GlY 
Ala 
tis 
Met 
Val 
Ile 
Leu 
TYr 
Phe 
Trp 
iys 
His 
Arg 
Lactotransferrin 
Mare Human Bovine 
72 71 71 
32 31 39 
48 50 45 
70 70 73 
33 35 31 
50 56 43 
71 63 59 
38 32 28 
3 6 4 
44 49 43 
14 16 17 
60 61 61 
20 20 19 
25 31 25 
12 11 9 
45 46 42 
10 9 10 
33 46 32 
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Table 2 
N-terminal sequence of mare lactotransferrin: comparison with human lactotransferrin [2], human serum transferrin 
[21] and hen ovotransferrin [22] 
Mare lactotransferrin 
Human lactotransferrin 
Human serum transferrin 
Hen ovotransferrin 
The one-letter amino acid abbreviation system is used. Gaps have been placed to maximize the homology. Boxed areas 
contain residues that are identical (0 ) or homologous (IX ) 
mare protein presented a more pronounced 
homology with hen ovotransferrin than with 
human lactotransferrin: the cluster of arginine 
residues was no longer present. However, when the 
whole of the so far determined N-terminal se- 
quence is considered, it presents an almost iden- 
tical homology with the other transferrins. 
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